Is VSQTF or MRK a better dividend investment in 2026?

VSQTF currently yields 593.47% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: VSQTF offers higher current income.

What is the dividend yield difference between VSQTF and MRK?

VSQTF has a forward dividend yield of 593.47% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 590.71 percentage points.

Home › Compare › VSQTF vs MRK

VSQTF vs MRK: Dividend Comparison 2026

VSQTF yields 593.47% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VSQTF wins by $236861.58M in total portfolio value

INVESTMENT

TIME HORIZON10 years

VSQTF

● Live price

593.47%

Share price

$0.34

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$236861.63M

Annual income

$177,895,500,601.46

Full VSQTF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — VSQTF vs MRK

📍 VSQTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VSQTF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VSQTF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VSQTF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VSQTF

Annual income on $10K today (after 15% tax)

$50,445.10/yr

After 10yr DRIP, annual income (after tax)

$151,211,175,511.24/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, VSQTF beats the other by $151,211,167,182.83/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VSQTF + MRK for your $10,000?

VSQTF: 50%MRK: 50%

100% MRK50/50100% VSQTF

Portfolio after 10yr

$118430.85M

Annual income

$88,947,755,199.80/yr

Blended yield

75.11%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VSQTF

No analyst data

Altman Z

1.0

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VSQTF buys

MRK buys

No recent congressional trades found for VSQTF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVSQTFMRK

Forward yield	593.47% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$236861.63M ✓	$56.8K
Annual income after 10y	$177,895,500,601.46 ✓	$9,798.13
Total dividends collected	$231928.66M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: VSQTF vs MRK ($10,000, DRIP)

Year	VSQTF Portfolio	VSQTF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$70,047	$59,347.18	$11,206	$366.19	+$58.8K → VSQTF
2	$463,465	$388,514.27	$12,650	$502.35	+$450.8K → VSQTF
3	$2,898,329	$2,402,421.77	$14,407	$694.19	+$2.88M → VSQTF
4	$17,142,161	$14,040,948.72	$16,585	$967.82	+$17.13M → VSQTF
5	$95,954,411	$77,612,299.18	$19,342	$1,363.89	+$95.94M → VSQTF
6	$508,690,028	$406,018,807.64	$22,913	$1,947.19	+$508.67M → VSQTF
7	$2,555,940,135	$2,011,641,805.81	$27,662	$2,823.89	+$2555.91M → VSQTF
8	$12,181,212,382	$9,446,356,436.87	$34,159	$4,173.35	+$12181.18M → VSQTF
9	$55,108,535,295	$42,074,638,046.51	$43,337	$6,308.80	+$55108.49M → VSQTF
10	$236,861,633,367	$177,895,500,601.46	$56,776	$9,798.13	+$236861.58M → VSQTF

VSQTF vs MRK: Complete Analysis 2026

VSQTF — Stock

Victory Square Technologies Inc. is a private equity and venture capital firm specializing in incubation, acquisition and invests in startups, Early stage and provides the senior leadership and resources needed to growth. Through its portfolio companies it focuses on technologies in blockchain, digital health, web3, creator economy, metaverse, machine learning, climate tech, youth, mental health, healthcare, special needs, technology, First Nation, artificial intelligence, and virtual reality/augmented reality, health, mobile gaming, film, esports, cannabis, and education. The company formerly known as Fantasy 6 Sports Inc. and changed its name to Victory Square Technologies Inc. in June 2017. It prefers to take minority investment in the companies. Victory Square Technologies Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada with an additional office in Lewes, Delaware.

Full VSQTF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this VSQTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VSQTF vs SCHD VSQTF vs JEPI VSQTF vs O VSQTF vs KO VSQTF vs MAIN VSQTF vs JNJ VSQTF vs ABBV VSQTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.